618
QUALITY OF LIFE IN PATIENTS WITH CHRONIC PANCREATITIS: A NATIONWIDE LONGITUDINAL COHORT STUDY
Date
May 8, 2023
Explore related products in the following collection:
Tracks
Related Products
IMPACT OF A NON-THERAPEUTIC LAPAROTOMY IN PATIENTS WITH LOCALLY ADVANCED PANCREATIC CANCER UNDERGOING SURGICAL EXPLORATION TREATED WITH INDUCTION (M)FOLFIRINOX; A TAPS CONSORTIUM STUDY
LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM
DEVELOPMENT OF PANCREATIC DISEASES DURING LONG-TERM FOLLOW-UP OF PATIENTS WITH ACUTE PANCREATITIS IN A PROSPECTIVE NATIONWIDE MULTICENTER COHORT
This session presents the best submitted clinical abstracts as determined by their specific council sections…
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
HABITUAL MEAT INTAKE IS ASSOCIATED WITH INCREASED RISK OF DISEASE FLARE IN ULCERATIVE COLITIS: INITIAL RESULTS FROM THE PREDICCT STUDY
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…